Pharma company Sandoz named in US price-fixing lawsuit
The Germany-based subsidiary of Swiss pharmaceutical giant Novartis is one of 20 companies in the United States targeted in a 44-state class action suit for breaching rules on fair competition.
This content was published on
1 minute
SDA-Keystone/ac
The names of the companies were revealed on SundayExternal link by Connecticut Attorney General William Tong. The lawsuit accuses the companies of inflating the prices of more than 100 different drugs.
“Sandoz’s name appears in a court case, which concerns virtually the entire pharmaceutical generics industry,” Novartis told the Swiss news agency AWP. According to the Basel-based parent company, the accusations are unfounded and will be contested vigorously.
The American prosecutor mentioned that “Teva, Sandoz, Mylan, Pfizer and 16 other generic producers” are accused of conspiring among themselves to set prices, allocate markets and distort offers of more than 100 generic products. In some cases, the price of some substances increased more than tenfold. In addition to Sandoz, a former vice president at the company, Armando Kellum, was named as an individual defendant in the case.
“We have hard evidence that shows the generic drug industry perpetrated a multi-billion-dollar fraud on the American people,” said Tong. “We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of generic drugs.
Swiss justice minister hopes EU reform will reduce irregular migration
This content was published on
The European Union’s (EU) New Pact on Migration and Asylum aims to curb irregular migration within Schengen, Justice Minister Beat Jans said on Tuesday.
Swiss electricity supply outlook positive despite uncertainties
This content was published on
Thanks to well-filled gas stores in Europe and increased availability of French nuclear power, the Swiss Federal Electricity Commission is optimistic.
Finance minister wants Swiss banks to hold more equity
This content was published on
Finance Minister Karin Keller-Sutter has repeated calls for banks and their holdings in subsidiaries abroad to hold more equity.
Telecoms sector kept Swiss competitions regulator busy in 2023
This content was published on
Last year, the Swiss Competition Commission (COMCO) conducted 27 investigations and initiated 17 preliminary investigations.
This content was published on
Although Swiss International Air Lines (SWISS) achieved higher revenue at the start of the year, it suffered a dip in profits.
40,000 signatures against animal testing in Switzerland
This content was published on
Switzerland should do away with “restrictive” animal testing and should become a model for innovative, effective, and pain-free scientific research.
More than 45,000 signatures in favour of federal funding for UNRWA
This content was published on
The Foreign Affairs Committee of the House of Representatives (FAC) is expected to decide on the funding of the UNRWA at the beginning of the week.
This content was published on
At the end of January 2024, 6,881 men and women were behind bars in Switzerland. Almost 95% of all places were occupied, the highest number since 2014.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.